We've told you about luxury pet cloning services in Asia, but now a California based biotech startup, BioArts International, has launched the Best Friends Again Program, a commercial dog cloning program. They received their worldwide license with exclusive rights to commercialise dog and cat cloning using the same technique used to produce Dolly, the first cloned sheep.
Five cloning slots are to be auctioned off for interested pet owners. Starting bids range from $100,000- $180,000, which is not cheap, but for some, price is no obstacle if they can get their beloved pets back in some form. The company is apparently collaborating with the South Korean cloning team lead by the disgraced senior scientist, Hwang Woo-Suk. According to BioArts International, the Korean team, with better technology, have improved the dog cloning success rate since the very first dog clone, Snuppy, was produced in 2005.
There is concern among the scientific community because animal clones are flawed. Dolly the sheep had numerous health problems and died young. The US Humane Society is also concerned about animal suffering. Even if the clones were perfect and no animal suffered any illnesses, clones are exactly that - carbon copies of a dear pet. They will look identical but the clones will not have the personality traits of the original which so endeared them to their owners.
Here's more on cloning:
Commercial Dog Cloning (Update)
More Stats +/-
Blockchain-Powered Medical Platforms
Marble-Imitating Foam Blocks
Psychedelic Streetwear Lookbooks
Cake-Flavored Protein Shakes
Politically Oriented Inclusive Events
Free 2018 Report & eBook
Get the top 100 trends happening right NOW -- plus a FREE copy of our award-winning book.
Our Research Methodology
This article is one of 350,000 experiments. We use crowd filtering, big data and AI to identify insights.